ATE245990T1 - Gemischter chimerismus und toleranz - Google Patents

Gemischter chimerismus und toleranz

Info

Publication number
ATE245990T1
ATE245990T1 AT00114769T AT00114769T ATE245990T1 AT E245990 T1 ATE245990 T1 AT E245990T1 AT 00114769 T AT00114769 T AT 00114769T AT 00114769 T AT00114769 T AT 00114769T AT E245990 T1 ATE245990 T1 AT E245990T1
Authority
AT
Austria
Prior art keywords
tolerance
mixed chimerism
chimerism
mixed
whole body
Prior art date
Application number
AT00114769T
Other languages
German (de)
English (en)
Inventor
Megan Sykes
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE245990T1 publication Critical patent/ATE245990T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Gloves (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
AT00114769T 1996-05-09 1997-05-08 Gemischter chimerismus und toleranz ATE245990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1709996P 1996-05-09 1996-05-09

Publications (1)

Publication Number Publication Date
ATE245990T1 true ATE245990T1 (de) 2003-08-15

Family

ID=21780711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00114769T ATE245990T1 (de) 1996-05-09 1997-05-08 Gemischter chimerismus und toleranz

Country Status (9)

Country Link
US (4) US6006752A (enExample)
EP (1) EP0918524A4 (enExample)
JP (1) JP2000511888A (enExample)
AT (1) ATE245990T1 (enExample)
AU (1) AU734665B2 (enExample)
CA (1) CA2253597A1 (enExample)
DE (1) DE69723888T2 (enExample)
ES (1) ES2201977T3 (enExample)
WO (1) WO1997041863A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871728A (en) 1995-03-31 1999-02-16 University Of Pittsburgh Method of regulating dendritic cell maturation
EP0918524A4 (en) * 1996-05-09 2000-11-08 Gen Hospital Corp MIXED CHIMERISM AND TOLERANCE
DE69841058D1 (de) 1997-11-14 2009-09-24 Gen Hospital Corp Behandlung von hämatologischen störungen
ATE265220T1 (de) 1998-02-04 2004-05-15 Gen Hospital Corp Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
EP1066052B1 (en) * 1998-03-18 2006-02-01 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
WO2000011147A1 (en) * 1998-08-20 2000-03-02 The General Hospital Corporation Inbred mhc-homozygous miniature swine and uses thereof
AU2980900A (en) * 1999-02-04 2000-08-25 General Hospital Corporation, The Methods for human allografting
AU3745900A (en) * 1999-03-15 2000-10-04 Modex Therapeutiques, S.A. Methods and compositions for tolerizing hosts for long term survival of tissue transplants
US6750023B2 (en) * 1999-09-02 2004-06-15 Corning Incorporated Porous inorganic substrate for high-density arrays
EP1257282A4 (en) * 1999-12-06 2003-05-02 Gen Hospital Corp PANCREATIC STEM CELLS AND THEIR USE IN TRANSPLANTATION
WO2001053825A1 (en) * 2000-01-19 2001-07-26 Biotransplant, Inc. Swine defective for transmission of porcine endogenous retrovirus and uses thereof
CA2427996A1 (en) * 2000-11-22 2002-06-06 Geron Corporation Tolerizing allografts of pluripotent stem cells
WO2002074938A1 (en) * 2001-03-20 2002-09-26 Trustees Of Amherst College Methods for producing antibodies in mammals
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
US20030031652A1 (en) * 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism
US20030032631A1 (en) * 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
US20050058641A1 (en) * 2002-05-22 2005-03-17 Siemionow Maria Z. Tolerance induction and maintenance in hematopoietic stem cell allografts
WO2003099330A1 (en) * 2002-05-22 2003-12-04 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
WO2005021734A2 (en) * 2003-09-02 2005-03-10 University Of Massachussets Generation of hematopoietic chimerism and induction of central tolerance
US20050266001A1 (en) * 2004-04-02 2005-12-01 Hadley Gregg A Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
US9561253B2 (en) 2013-02-26 2017-02-07 The Board Of Trustees Of The Leland Stanford Junior University Combined organ and hematopoietic cells for transplantation tolerance of grafts
CN105188741A (zh) 2013-04-03 2015-12-23 阿勒丁医疗公司 新型纳米颗粒组合物
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
US12058986B2 (en) 2017-04-20 2024-08-13 Egenesis, Inc. Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements
US11273179B2 (en) 2018-03-12 2022-03-15 Medeor Therapeutics, Inc. Methods for treating non-cancerous disorders using hematopoietic cells
US10842821B2 (en) 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US11813376B2 (en) 2018-09-18 2023-11-14 Medeor Therapeutics, Inc. Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof
US11435350B2 (en) 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT621786E (pt) * 1992-01-08 2002-07-31 Gen Hospital Corp Inducao da tolerancia a xenoenxertos
US5658564A (en) * 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5597563A (en) * 1992-09-04 1997-01-28 Beschorner; William E. Method induction of antigen-specific immune tolerance
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
EP0918524A4 (en) 1996-05-09 2000-11-08 Gen Hospital Corp MIXED CHIMERISM AND TOLERANCE
ATE265220T1 (de) * 1998-02-04 2004-05-15 Gen Hospital Corp Kostimulatorische blockade und gemischter chimerismus in allotransplantationen

Also Published As

Publication number Publication date
EP0918524A1 (en) 1999-06-02
DE69723888T2 (de) 2004-05-27
US6412492B1 (en) 2002-07-02
US20030075187A1 (en) 2003-04-24
DE69723888D1 (de) 2003-09-04
CA2253597A1 (en) 1997-11-13
AU734665B2 (en) 2001-06-21
US20040247579A1 (en) 2004-12-09
AU3120397A (en) 1997-11-26
JP2000511888A (ja) 2000-09-12
EP0918524A4 (en) 2000-11-08
WO1997041863A1 (en) 1997-11-13
US6718986B2 (en) 2004-04-13
US6006752A (en) 1999-12-28
ES2201977T3 (es) 2004-04-01
US6877514B2 (en) 2005-04-12

Similar Documents

Publication Publication Date Title
DE69723888D1 (de) Gemischter Chimerismus und Toleranz
FR10C0016I1 (enExample)
DE3670776D1 (de) System und zentrifugaloxygenator zur klaerung von abwasser.
DE3889245D1 (de) Integrierter und kontrollierter Leistungs-MOSFET.
DE69725961D1 (de) Befestigumgsvorrichtung und damit versehene prothese
NO891896D0 (no) Fremgangsmaate og innretning for behandling av medisinsk spesialavfall.
DE69731736D1 (de) Injektionsbehandlung zur beherrschung von muskelkrämpfen und damit einhergehenden schmerzen
FI953642A7 (fi) Jätevedenkäsittelymenetelmä ja -laite
PL330071A1 (en) Improved phototherapeutic methods and apparatus for irradiating columnar environments
DE69805438D1 (de) Misch- und ladeöffnung zur medizinischen behandlung
DE69523888D1 (de) Feldemissionskathode und diese kathode verwendende vorrichtung
DE69303214D1 (de) Zusammensetzungen und Methoden zur Gaslochbehandlung
DE69214156D1 (de) Bipolare temporäre schrittmacherleitung und kupplung
DE69506037D1 (de) Audioausgabeeinheit und Methode
DE3851121D1 (de) Filamentlose Magnetron-Ionenquelle und Verwendungsverfahren.
DE69518099D1 (de) Leistungsverstärker und Verfahren dazu
EE9600094A (et) Heitvee puhastusmeetod ja -seade
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
NO900696D0 (no) Fremgangsmaate og anordning for biologisk behandling omfattende nitrifisering og denitrifisering av avloepsvann.
BR9507859A (pt) Aparelho e método de registro flexivel de múltiplos subcanais
DE69522599D1 (de) Aufkohlungshärtungsverfahren und dadurch hergestellte Kraftübertragungselemente
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
NO985068L (no) Vaksiner for behandling av lymfom og leukemi
DE69602704D1 (de) Zyklotron und Regelverfahren dazu

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties